Infusion of hESC derived Immunity-and-matrix regulatory cells improves cognitive ability in early-stage AD mice.
Jing LiuZongren HouJun WuKailun LiuDa LiTingting GaoWenjing LiuBin AnYun SunFan MoLiu WangYukai WangJie HaoBao-Yang HuPublished in: Cell proliferation (2021)
We have shown that peripheral administration of IMRCs can ameliorate AD pathology and associated cognitive deficits.